NCT06823505

Brief Summary

Type of study: The goal of this observational study is to explore the relationship between patients with advanced lung cancer and their parent-child interactions during the treatment process, and to understand the impact of the degree of self-differentiation of parents with advanced lung cancer on the physical and mental health of their children. The main questions it aims to answer are:

  1. 1.To explore the post-illness adjustment process of patients with advanced lung cancer and the changes in the parent-child relationship among adolescents.
  2. 2.To explore the changes in demographic factors-self-belief, mental health, and self-efficacy among patients with advanced lung cancer-and the parent-child relationship among adolescents.
  3. 3.Explore the family resilience of patients with advanced lung cancer - family peer relationships, and the interaction between parent-child relationships among adolescents.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 12, 2025

Completed
Last Updated

February 12, 2025

Status Verified

August 1, 2023

Enrollment Period

1.1 years

First QC Date

June 24, 2024

Last Update Submit

February 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Parent-child interaction

    The interaction between patients with advanced lung cancer and their parents and children during the treatment process

    one years

  • Center for Epidemiological Studies Depression Scale

    The CES-D scale is designed to measure an individual's depression level, covering multiple aspects such as depressed mood, guilt, helplessness, decreased appetite, sleep disturbance and psychomotor retardation, with a total of 20 items. The subjects evaluated the frequency of each symptom in the past week using a four-point scale (1 point: never or rarely; 4 points: often). Studies have shown that CES-D has good internal consistency (α=0.85) (Conerly et al., 2002; Given et al., 2004) and reliability (Cronbach's alpha \> 0.85) in cancer patients (Hann et al., 2004). al., 1999) , and therefore can effectively assess the level of depression in cancer patients. In short, the CES-D is a validated tool for assessing depression in cancer patients.

    one years

Interventions

Using the Depression Scale (CES-D), Cancer Self-Efficacy Scale (CASE), Family Peer Relationship Questionnaire (FPRQ), Family Resilience Scale (FRAS) and Parent-Child Relationship Quality Scale

Eligibility Criteria

Age40 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients with advanced lung cancer aged 40 to 64 years, and have aged 10 to 19 years old teenagers.

You may qualify if:

  • Patients with advanced lung cancer aged 40 to 64 years (mid-adulthood).
  • There are lung cancer patients in the family who are teenagers aged 10 to 19 years old.
  • Those who voluntarily participate in this study.
  • Voluntary participants can express themselves orally and in handwriting.

You may not qualify if:

  • Single lung cancer patients over 65 years old.
  • Lung cancer patients under 40 years old.
  • Patients diagnosed with early-stage lung cancer.
  • Those who have cognitive impairment and are unable to understand the problem.
  • Those who are unable to express and respond to questions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Taiwan University Hospital

Taipei, Taipei City, 100225, Taiwan

Location

Nation Taiwan University Hospital

Taipei, Taiwan, 100225, Taiwan

Location

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2024

First Posted

February 12, 2025

Study Start

December 17, 2023

Primary Completion

January 21, 2025

Study Completion

January 21, 2025

Last Updated

February 12, 2025

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations